Manhattan Scientifics Inc (MHTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38 | 51 | 67 | 89 | 52 |
| TOTAL | $45 | $60 | $69 | $90 | $61 |
| Non-Current Assets | |||||
| Investments And Advances | 27 | 29 | 245 | 340 | 506 |
| Other Non-Current Assets | 2 | 2 | 2 | 2 | 2 |
| TOTAL | $29 | $31 | $247 | $342 | $508 |
| Total Assets | $74 | $91 | $316 | $432 | $569 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 156 | 147 | 133 | 128 | 125 |
| Accrued Expenses | 2,180 | 2,048 | 1,915 | 1,782 | 1,650 |
| TOTAL | $2,416 | $2,275 | $2,118 | $1,980 | $1,855 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 20 | 20 | 10 | 10 | 10 |
| Other Non-Current Liabilities | 1,058 | 1,058 | 1,058 | 1,058 | 1,058 |
| TOTAL | $1,058 | $1,058 | $1,058 | $1,058 | $1,058 |
| Total Liabilities | $3,474 | $3,333 | $3,176 | $3,038 | $2,913 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 559,281 | 559,281 | 559,281 | 559,281 | 559,281 |
| Common Shares | 559 | 559 | 559 | 559 | 559 |
| Retained earnings | -72,955 | -72,797 | -72,415 | -72,161 | -71,899 |
| TOTAL | $-3,400 | $-3,242 | $-2,860 | $-2,606 | $-2,344 |
| Total Liabilities And Equity | $74 | $91 | $316 | $432 | $569 |